Vistagen to Proceed with PALISADE-2 Phase 3 Clinical Trial of PH94B in Social Anxiety Disorder following Interim Analysis

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen's PALISADE-2 clinical trial to resume after interim analysis by independent biostatisticians recommends continuation without any changes

Click to view original post